Study of AVB-401 for the treatment of BAG3-mediated dilated cardiomyopathy
Latest Information Update: 08 Jan 2024
At a glance
- Drugs AVB 401 (Primary)
- Indications Dilated cardiomyopathy
- Focus Adverse reactions
- 08 Jan 2024 New trial record
Latest Information Update: 08 Jan 2024